| Naslov: | Assessment of kidney function : clinical indications for measured GFR |
|---|
| Avtorji: | ID Ebert, Natalie (Avtor)
ID Bevc, Sebastjan (Avtor)
ID Bökenkamp, Arend (Avtor)
ID Gaillard, Francois (Avtor)
ID Hornum, Mads (Avtor)
ID Jager, Kitty (Avtor)
ID Mariat, Christophe (Avtor)
ID Eriksen, Bjørn Odvar (Avtor)
ID Palsson, Runolfur (Avtor)
ID Rule, Andrew D. (Avtor), et al. |
|---|
| Datoteke: |  Ebert-2021-Assessment_of_kidney_function__clin.pdf (607,93 KB)
MD5: 9D0A120812E96A06C80DDBA5DC1B4414
 https://doi.org/10.1093/ckj/sfab042
|
|---|
| Jezik: | Angleški jezik |
|---|
| Vrsta gradiva: | Znanstveno delo |
|---|
| Tipologija: | 1.02 - Pregledni znanstveni članek |
|---|
| Organizacija: | MF - Medicinska fakulteta
|
|---|
| Opis: | In the vast majority of cases, glomerular filtration rate (GFR) is estimated using serum creatinine, which is highly influenced by age, sex, muscle mass, body composition, severe chronic illness and many other factors. This often leads to misclassification of patients or potentially puts patients at risk for inappropriate clinical decisions. Possible solutions are the use of cystatin C as an alternative endogenous marker or performing direct measurement of GFR using an exogenous marker such as iohexol. The purpose of this review is to highlight clinical scenarios and conditions such as extreme body composition, Black race, disagreement between creatinine- and cystatin C–based estimated GFR (eGFR), drug dosing, liver cirrhosis, advanced chronic kidney disease and the transition to kidney replacement therapy, non-kidney solid organ transplant recipients and living kidney donors where creatinine-based GFR estimation may be invalid. In contrast to the majority of literature on measured GFR (mGFR), this review does not include aspects of mGFR for research or public health settings but aims to reach practicing clinicians and raise their understanding of the substantial limitations of creatinine. While including cystatin C as a renal biomarker in GFR estimating equations has been shown to increase the accuracy of the GFR estimate, there are also limitations to eGFR based on cystatin C alone or the combination of creatinine and cystatin C in the clinical scenarios described above that can be overcome by measuring GFR with an exogenous marker. We acknowledge that mGFR is not readily available in many centres but hope that this review will highlight and promote the expansion of kidney function diagnostics using standardized mGFR procedures as an important milestone towards more accurate and personalized medicine. |
|---|
| Ključne besede: | biomarker, chronic kidney disease, clinical indications, creatinine, cystatin C, kidney function, measured glomerular filtration rate |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Poslano v recenzijo: | 01.12.2020 |
|---|
| Datum sprejetja članka: | 11.02.2021 |
|---|
| Datum objave: | 22.02.2021 |
|---|
| Založnik: | Oxford University Press |
|---|
| Leto izida: | 2021 |
|---|
| Št. strani: | Str. 1861-1870 |
|---|
| Številčenje: | Letn. 14, Št. 8 |
|---|
| PID: | 20.500.12556/DKUM-89781  |
|---|
| UDK: | 616.6 |
|---|
| COBISS.SI-ID: | 104360451 |
|---|
| DOI: | 10.1093/ckj/sfab042 |
|---|
| ISSN pri članku: | 2048-8513 |
|---|
| Datum objave v DKUM: | 12.08.2024 |
|---|
| Število ogledov: | 198 |
|---|
| Število prenosov: | 18 |
|---|
| Metapodatki: |    |
|---|
| Področja: | Ostalo
|
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Skupna ocena: | (0 glasov) |
|---|
| Vaša ocena: | Ocenjevanje je dovoljeno samo prijavljenim uporabnikom. |
|---|
| Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
